Skip to main content
Powered by
buzzwords.news
(
US Patent 11,232,363 B2
) · created by
d-e-v.com
buzzwords.technology
main_menu
Home
Channels
Personalize
Headlines
Alexa Skill
Search
Search
Home
Headlines
Genentech : Phase III Study Of Alecensa In ALK-Positive Early-Stage Lung Cancer Meets Main Goal
posted:
Fri, 09/01/2023 - 01:40 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
AI in Fintech Has Been Slow to Start, But Look for a Second Phase of Investment Opportunities
posted:
Thu, 08/31/2023 - 13:11 EDT
by:
Nasdaq Innovation
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqInnovation
,
#Technology
,
#Innovation
VettaFi’s Dave Nadig on AI: "We Should Be in That Critical Learning Phase"
posted:
Wed, 08/30/2023 - 17:15 EDT
by:
Nasdaq ETFs
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqETFs
,
#ETFs
,
#Stocks
Novocure : Phase 3 Trial In Platinum-resistant Ovarian Cancer Fails To Meet Main Goal; Stock Plunges
posted:
Mon, 08/28/2023 - 07:46 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Amgen : Olpasiran Phase 2 Data Shows Continued Reduction Of Lp(a) Nearly A Year After Last Dose
posted:
Sat, 08/26/2023 - 11:06 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
GSK Plc Reports 100% Vaccine Efficacy From Post-license Phase IV Trial Of Shingrix In China
posted:
Wed, 08/23/2023 - 02:17 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Genentech Issues Update On Phase III SKYSCRAPER-01 Study - Quick Facts
posted:
Wed, 08/23/2023 - 02:00 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Exelixis, Ipsen Reports Positive Phase 3 CONTACT-02 Study Data In Prostate Cancer
posted:
Mon, 08/21/2023 - 01:51 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
HUTCHMED : Sovleplenib Phase III ESLIM-01 Study Meets Main Goal In Primary Immune Thrombocytopenia
posted:
Sun, 08/20/2023 - 21:38 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Netflix Stock (NASDAQ:NFLX): The Growth Phase is Over. Time to Sell?
posted:
Fri, 08/18/2023 - 15:55 EDT
by:
Nasdaq NFLX NetFlix
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#NFLX
,
#NetFlix
EXCLUSIVE-H&M says it will "phase out" sourcing from Myanmar
posted:
Thu, 08/17/2023 - 09:43 EDT
by:
Nasdaq Commodities
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqCommodities
,
#Commodities
,
#Stocks
EXCLUSIVE-H&M says it will "phase out" sourcing from Myanmar
posted:
Thu, 08/17/2023 - 09:28 EDT
by:
Nasdaq Commodities
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqCommodities
,
#Commodities
,
#Stocks
Arcellx: Partial Clinical Hold Lifted By FDA On IMMagine-1 Phase 2 Trial; Q2 Net Loss Narrows
posted:
Wed, 08/16/2023 - 02:05 EDT
by:
Nasdaq Markets
#channels::
#All
,
#Business
,
#Nasdaq
,
#NasdaqMarkets
,
#Stocks
,
#Markets
Indian refiner MRPL to phase out exports as it adds retail outlets
posted:
Mon, 08/14/2023 - 04:08 EDT
by:
Nasdaq FB FaceBook
#channels::
#All
,
#Business
,
#Technology
,
#Nasdaq
,
#Stocks
,
#FB
,
#FaceBook
,
#MetaPlatforms
,
#META
Commodore Capital Buys in for the Long Haul With 20% Vistagen Stake on Promising Phase 3 Data
posted:
Fri, 08/11/2023 - 06:55 EDT
by:
Nasdaq Stocks
#channels::
#All
,
#Business
,
#Stocks
,
#Nasdaq
,
#NasdaqStocks
Pagination
Previous page
‹‹
Page 11
Next page
››